User menu

Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study

Bibliographic reference Larock, Anne-Sophie ; Mullier, François ; Sennesael, Anne-Laure ; Douxfils, Jonathan ; Devalet, Bérangère ; et. al. Appropriateness of prescribing dabigatran etexilate and rivaroxaban in patients with nonvalvular atrial fibrillation: a prospective study. In: The Annals of Pharmacotherapy, Vol. 48, no. 10, p. 1258-1268 (2014)
Permanent URL
  1. ten Cate Hugo, New oral anticoagulants: discussion on monitoring and adherence should start now!, 10.1186/1477-9560-11-8
  2. Hussain Sahar, Gebran Nicole, Hussain Kosar, Soliman Karem, Drug use evaluation of dabigatran in a tertiary care hospital in United Arab Emirates, 10.1136/ejhpharm-2012-000169
  3. Lim Sueh-li A, Maxwell Ellen, An audit of dabigatran etexilate prescribing in Victoria, 10.5694/mja12.10942
  4. Hanlon Joseph T., Schmader Kenneth E., Samsa Gregory P., Weinberger Morris, Uttech Kay M., Lewis Ingrid K., Cohen Harvey Jay, Feussner John R., A method for assessing drug therapy appropriateness☆, 10.1016/0895-4356(92)90144-c
  5. Spinewine Anne, Schmader Kenneth E, Barber Nick, Hughes Carmel, Lapane Kate L, Swine Christian, Hanlon Joseph T, Appropriate prescribing in elderly people: how well can it be measured and optimised?, 10.1016/s0140-6736(07)61091-5
  6. Spinewine Anne, Swine Christian, Dhillon Soraya, Lambert Philippe, Nachega Jean B., Wilmotte Léon, Tulkens Paul M., Effect of a Collaborative Approach on the Quality of Prescribing for Geriatric Inpatients: A Randomized, Controlled Trial : IMPROVING QUALITY OF DRUG USE IN ELDERLY INPATIENTS, 10.1111/j.1532-5415.2007.01132.x
  7. Spinewine Anne, Dumont Christophe, Mallet Louise, Swine Christian, MEDICATION APPROPRIATENESS INDEX: RELIABILITY AND RECOMMENDATIONS FOR FUTURE USE : LETTERS TO THE EDITOR, 10.1111/j.1532-5415.2006.00668_8.x
  8. Kirley K., Qato D. M., Kornfield R., Stafford R. S., Alexander G. C., National Trends in Oral Anticoagulant Use in the United States, 2007 to 2011, 10.1161/circoutcomes.112.967299
  9. Dager W. E., Gulseth M. P., Implementing anticoagulation management by pharmacists in the inpatient setting, 10.2146/ajhp060133
  10. Reilly Paul A., Lehr Thorsten, Haertter Sebastian, Connolly Stuart J., Yusuf Salim, Eikelboom John W., Ezekowitz Michael D., Nehmiz Gerhard, Wang Susan, Wallentin Lars, The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients, 10.1016/j.jacc.2013.07.104
  11. De Caterina Raffaele, Husted Steen, Wallentin Lars, De Caterina Raffaele, Husted Steen, Wallentin Lars, Andreotti Felicita, Arnesen Harald, Bachmann Fedor, Baigent Colin, Huber Kurt, Jespersen Jørgen, Kristensen Steen Dalby, Lip Gregory Y.H., Morais João, Rasmussen Lars Hvilsted, Siegbahn Agneta, Verheugt Freek W.A., Weitz Jeffrey I., New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes, 10.1016/j.jacc.2012.02.008